ÀÎÁ¦´ëÇб³Àǰú´ëÇÐ ¾à¹°À¯ÀüÁ¦¿¬±¸¼¾ÅÍ

°øÁö»çÇ×

³»¿ëºÐ·ù Á¤±â¼¼¹Ì³ª
°Ô½ÃÀÚ PGRC ()
Á¦¸ñ [PGRC]±Ý¿ä Àú³ÎŬ·´ °øÁö(2016/06/10)
ÂüÁ¶URL  ÂüÁ¶URL Á¤º¸¾øÀ½.
ÂüÁ¶ÆÄÀÏ  ÆÄÀϾøÀ½
³»¿ë
¾à¹°À¯Àüü¿¬±¸¼¾ÅÍ¿¡¼­´Â ´ÙÀ½°ú °°Àº ³»¿ëÀ¸·Î ¼¼¹Ì³ª¸¦ °³ÃÖÇÕ´Ï´Ù.
°ü½É ÀÖ´Â ±³¼ö´Ô, ¿¬±¸¿ø ¿©·¯ºÐÀÇ Àû±ØÀûÀÎ Âü¿© ¹Ù¶ø´Ï´Ù.



1) Àú³ÎŬ·´ ¿¬Á¦
- Immobilized Cytochrome P450 for Monitoring of P450-P450
Interactions and Metabolism
-Solitary Inhibition of the Breast Cancer Resistance Protein Efflux
Transporter Results in a Clinically Significant Drug-Drug Interaction
with Rosuvastatin by Causing up to a 2-Fold Increase in Statin Exposure

2) Àú³ÎŬ·´ ¿¬ÀÚ
- À̸íÁø / Á¶¹®ÁÖ ÃÖ¿µ°æ
- Phuong / ÀÓ´ÙÀº ÀÓ¼öÁ¤ Â÷Àº¿µ

3) ÀÏ ½Ã : 2016³â 06 ¿ù 10 ÀÏ (±Ý) ¿ÀÈÄ 4½Ã ~ 5½Ã

4) Àå ¼Ò : Àǰú´ëÇÐ 805È£